Gilead Issues A Voluntary Nationwide Recall of Two Lots of Veklury® (Remdesivir) Due to Presence of Glass Particulates

Date: 12/03/2021

Product type: Drugs, Potential Foreign Material

Company Announcement Date: December 03, 2021
FDA Publish Date: December 03, 2021
Product Type: Drugs
Reason for Announcement: Presence of glass particulates
Company Name: Gilead Sciences Inc.
Brand Name: Gilead
Product Description: Veklury® (remdesivir 100 mg for injection)

US-FDA Link: